Profile data is unavailable for this security.
About the company
Shanrong Biotechnology Corp. is a holding company for select biotechnology, health, and wellness operations. The Company owns and operates three patents: Long-lasting preparation of long-term stable intravenous melatonin injectable addressing sepsis, bacterial pathologies, and other inflammatory pathology; new melatonin formulations for the treatment of chemotherapy-resistant tumors addressing cancer (head and neck, prostate, breast, ovarian, melanoma) and injectable melatonin composition for the treatment of viral diseases addressing COVID-19 and other viral diseases.
- Revenue in USD (TTM)1.32m
- Net income in USD-5.08m
- Incorporated2007
- Employees3.00
- LocationShanrong Biotechnology Corp707 Eagleview BlvdEXTON 19341-1159United StatesUSA
- Phone+1 (610) 833-6000
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shanrong Biotechnology Corp | 1.32m | -5.08m | 69.19k | 3.00 | -- | -- | -- | 0.0522 | -15.40 | -15.40 | 4.10 | -11.40 | 4.45 | -- | 11.81 | 441,576.70 | -1,705.30 | -- | -- | -- | -- | -- | -383.32 | -- | 0.0315 | -16.22 | -- | -- | 91.44 | -- | -86.62 | -- | -- | -- |
| Baltic International USA Inc | 0.00 | -183.44k | 99.88k | -- | -- | -- | -- | -- | -0.0167 | -0.0167 | 0.00 | -0.4425 | 0.00 | -- | -- | -- | -850.34 | -849.13 | -- | -- | -- | -- | -- | -- | -- | -1.61 | -- | -- | -- | -- | 0.00 | -- | -- | -- |
Data as of Jun 25 2024. Currency figures normalised to Shanrong Biotechnology Corp's reporting currency: US Dollar USD
